Lesubiz 25 Tablet contains Levosulpiride 25 mg, a selective dopamine D2 receptor antagonist primarily used in the treatment of gastrointestinal motility disorders and certain psychiatric conditions. Levosulpiride exerts prokinetic effects by enhancing gastric emptying and improving esophageal motility, making it effective in managing symptoms associated with functional dyspepsia, gastroesophageal reflux disease (GERD), and irritable bowel syndrome (IBS). Additionally, its central dopaminergic antagonism contributes to its efficacy in treating psychotic disorders, depression, and anxiety-related conditions. Lesubiz 25 is indicated for patients experiencing nausea, vomiting, bloating, and abdominal discomfort due to delayed gastric emptying or impaired gastrointestinal motility. The standard dosage should be adhered to as prescribed by a healthcare professional to minimize potential side effects, which may include extrapyramidal symptoms, sedation, and hyperprolactinemia. Caution is advised in patients with a history of hypersensitivity to sulpiride or related compounds, and it should be used with care in individuals with renal or hepatic impairment. Lesubiz 25 Tablet should not be combined with other dopamine antagonists without medical supervision. Regular monitoring and consultation with a healthcare provider are recommended to ensure therapeutic efficacy and safety during treatment.